A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD0914

Status:
Completed

Trial end date:
2014-03-01

Target enrollment:

Participant gender:

The purpose of this study is to assess the safety and tolerability of orally administered AZD0914 in healthy adult subjects.

Phase 1

AstraZeneca